agilon health, inc. (AGL)
NYSE: AGL · IEX Real-Time Price · USD
5.41
-0.17 (-3.05%)
May 17, 2024, 4:00 PM EDT - Market closed
agilon health Revenue
agilon health had revenue of $4.78B in the twelve months ending March 31, 2024, with 71.55% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.60B with 52.17% year-over-year growth. In the year 2023, agilon health had annual revenue of $4.32B with 80.74% growth.
Revenue (ttm)
$4.78B
Revenue Growth
+71.55%
P/S Ratio
0.47
Revenue / Employee
$4,283,411
Employees
1,117
Market Cap
2.23B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.32B | 1.93B | 80.74% |
Dec 31, 2022 | 2.39B | 866.73M | 56.97% |
Dec 31, 2021 | 1.52B | 303.16M | 24.88% |
Dec 31, 2020 | 1.22B | 423.92M | 53.36% |
Dec 31, 2019 | 794.41M | 319.58M | 67.31% |
Dec 31, 2018 | 474.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Patterson Companies | 6.57B |
AMN Healthcare Services | 3.48B |
CONMED | 1.26B |
Myriad Genetics | 774.20M |
Vericel | 207.78M |
Deciphera Pharmaceuticals | 174.91M |
Arvinas | 71.30M |
Recursion Pharmaceuticals | 46.24M |
AGL News
- 3 hours ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 1 day ago - AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit - PRNewsWire
- 1 day ago - DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 1 day ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in agilon health Lawsuit - AGL - Accesswire
- 2 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGL - PRNewsWire
- 2 days ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 2 days ago - agilon health, inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL - Accesswire
- 3 days ago - May 20, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AGL - PRNewsWire